Valéria de Oliveira
Research Subjects
Valéria de Oliveira has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
Fabiana Cristina Pimenta
Laboratório de Bacteriologia, Instituto de Patologia Tropical e Saúde Pública, Universidade Federal de Goiás, Goiânia, GO, Brasil
3 shared publications- Rodolpho Campos Braga
InsilicAll Ltda
2 shared publications Wolf Christian Luz
Laboratório de Bacteriologia, Instituto de Patologia Tropical e Saúde Pública, Universidade Federal de Goiás, Goiânia, GO, Brasil
2 shared publications- Andréa C.B. Tôrres
Department of Imaging, School of Medicine, Universidad Andrés Bello, Santiago, Chile
1 shared publication Camille B. Persiano
Escola de Veterinária, Universidade Federal de Goiás, Goiânia, GO, Brazil
1 shared publication- Carlos Alberto Manssour Fraga
Laboratório de Avaliação e Síntese de Substâncias Bioativas (LASSBio), Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Cidade Universitária, Rio de Janeiro 21941-902, Brazil
1 shared publication
Latest Publications
- 31 May 2012
- Published by Elsevier in Journal of Bioscience and Bioengineering
- Vol. 113 (5) , 611-613
Microbial β-glycosylation of entacapone by Cunninghamella echinulata ATCC 9245
- 31 May 2012
- Published by Elsevier in Journal of Bioscience and Bioengineering
- Vol. 113 (5) , 611-613
Microbial β-glycosylation of entacapone by Cunninghamella echinulata ATCC 9245
- 1 July 2011
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 55 (5) , 1024-1030
Determination of the cardioactive prototype LASSBio-294 and its metabolites in dog plasma by LC–MS/MS: Application for a pharmacokinetic study
- 1 July 2011
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 55 (5) , 1024-1030
Determination of the cardioactive prototype LASSBio-294 and its metabolites in dog plasma by LC–MS/MS: Application for a pharmacokinetic study
- Open Access
- 1 June 2011
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Pharmaceutical Sciences
- Vol. 47 (2) , 209-230
Twenty-six years of HIV science: an overview of anti-HIV drugs metabolism
From the identification of HIV as the agent causing AIDS, to the development of effective antiretroviral drugs, the scientific achievements in HIV research over the past twenty-six years have been formidable. Currently, there are twenty-five anti-HIV compounds which have been formally approved for clinical use in the treatment of AIDS. These compounds fall into six categories: nucleoside reverse transcriptase inhibitors (NRTIs), nucleotide reverse transcriptase inhibitors (NtRTIs), non-nucleoside reverse transcriptase inhibitors (NNRTIs), protease inhibitors (PIs), cell entry inhibitors or fusion inhibitors (FIs), co-receptor inhibitors (CRIs), and integrase inhibitors (INIs). Metabolism by the host organism is one of the most important determinants of the pharmacokinetic profile of a drug. Formation of active or toxic metabolites will also have an impact on the pharmacological and toxicological outcomes. Therefore, it is widely recognized that metabolism studies of a new chemical entity need to be addressed early in the drug discovery process. This paper describes an overview of the metabolism of currently available anti-HIV drugs.
- 1 June 2011
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Pharmaceutical Sciences
- Vol. 47 (2) , 209-230
Open AccessTwenty-six years of HIV science: an overview of anti-HIV drugs metabolism
From the identification of HIV as the agent causing AIDS, to the development of effective antiretroviral drugs, the scientific achievements in HIV research over the past twenty-six years have been formidable. Currently, there are twenty-five anti-HIV compounds which have been formally approved for clinical use in the treatment of AIDS. These compounds fall into six categories: nucleoside reverse transcriptase inhibitors (NRTIs), nucleotide reverse transcriptase inhibitors (NtRTIs), non-nucleoside reverse transcriptase inhibitors (NNRTIs), protease inhibitors (PIs), cell entry inhibitors or fusion inhibitors (FIs), co-receptor inhibitors (CRIs), and integrase inhibitors (INIs). Metabolism by the host organism is one of the most important determinants of the pharmacokinetic profile of a drug. Formation of active or toxic metabolites will also have an impact on the pharmacological and toxicological outcomes. Therefore, it is widely recognized that metabolism studies of a new chemical entity need to be addressed early in the drug discovery process. This paper describes an overview of the metabolism of currently available anti-HIV drugs.
- Open Access
- 1 June 2008
- Vol. 39 (2) , 405-408
Selection of filamentous fungi of the Beauveria genus able to metabolize quercetin like mammalian cells
Microbial biotransformations constitute an important alternative as models for drug metabolism study in mammalians and have been used for the industrial synthesis of chemicals with pharmaceutical purposes. Several microorganisms with unique biotransformation ability have been found by intensive screening and put in commercial applications. Ten isolates of Beauveria sp genus filamentous fungi, isolated from soil in the central Brazil, and Beauveria bassiana ATCC 7159 were evaluated for their capability of quercetin biotransformation. Biotransformation processes were carried out for 24 up to 96 hours and monitored by mass spectrometry analyses of the culture broth. All strains were able to metabolize quercetin, forming mammalian metabolites. The results were different from those presented by other microorganisms previously utilized, attrackting attention because of the great diversity of reactions. Methylated, sulphated, monoglucuronidated, and glucuronidated conjugated metabolites were simultaneously detected.
- 1 June 2008
- Vol. 39 (2) , 405-408
Open AccessSelection of filamentous fungi of the Beauveria genus able to metabolize quercetin like mammalian cells
Microbial biotransformations constitute an important alternative as models for drug metabolism study in mammalians and have been used for the industrial synthesis of chemicals with pharmaceutical purposes. Several microorganisms with unique biotransformation ability have been found by intensive screening and put in commercial applications. Ten isolates of Beauveria sp genus filamentous fungi, isolated from soil in the central Brazil, and Beauveria bassiana ATCC 7159 were evaluated for their capability of quercetin biotransformation. Biotransformation processes were carried out for 24 up to 96 hours and monitored by mass spectrometry analyses of the culture broth. All strains were able to metabolize quercetin, forming mammalian metabolites. The results were different from those presented by other microorganisms previously utilized, attrackting attention because of the great diversity of reactions. Methylated, sulphated, monoglucuronidated, and glucuronidated conjugated metabolites were simultaneously detected.
- Open Access
- 1 June 2008
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Microbiology
- Vol. 39 (2) , 405-408
Selection of filamentous fungi of the Beauveria genus able to metabolize quercetin like mammalian cells
Microbial biotransformations constitute an important alternative as models for drug metabolism study in mammalians and have been used for the industrial synthesis of chemicals with pharmaceutical purposes. Several microorganisms with unique biotransformation ability have been found by intensive screening and put in commercial applications. Ten isolates of Beauveria sp genus filamentous fungi, isolated from soil in the central Brazil, and Beauveria bassiana ATCC 7159 were evaluated for their capability of quercetin biotransformation. Biotransformation processes were carried out for 24 up to 96 hours and monitored by mass spectrometry analyses of the culture broth. All strains were able to metabolize quercetin, forming mammalian metabolites. The results were different from those presented by other microorganisms previously utilized, attrackting attention because of the great diversity of reactions. Methylated, sulphated, monoglucuronidated, and glucuronidated conjugated metabolites were simultaneously detected. Biotransformações microbianas constituem uma alternativa importante como modelo para o estudo do metabolismo de medicamentos em mamíferos e são empregadas em processos sintéticos industriais com propósitos farmacêuticos. Diversos microrganismos com potencial para biotransformação têm sido encontrados através de screening intensivo e aplicados comercialmente. Dez cepas de fungos filamentosos do gênero Beauveria, isolados na região central do Brasil, e a cepa Beauveria bassiana ATCC 7159 foram avaliadas quanto à capacidade de biotransformação da quercetina. As reações de biotransformações foram realizadas por um período de 24 a 96 horas, e monitoradas através de espectrometria de massas do meio reacional. Todas as cepas foram capazes de metabolizar a quercetina, formando metabólitos encontrados nos mamíferos. Os resultados foram diferentes dos resultados apresentados por outros microrganismos utilizados anteriormente e chamam a atenção devido à diversidade das reações evidenciadas. Diferentes metabólitos conjugados foram detectados simultaneamente: metilados, sulfatados, monoglicuronados, e glicuronados
- 1 June 2008
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Microbiology
- Vol. 39 (2) , 405-408
Open AccessSelection of filamentous fungi of the Beauveria genus able to metabolize quercetin like mammalian cells
Microbial biotransformations constitute an important alternative as models for drug metabolism study in mammalians and have been used for the industrial synthesis of chemicals with pharmaceutical purposes. Several microorganisms with unique biotransformation ability have been found by intensive screening and put in commercial applications. Ten isolates of Beauveria sp genus filamentous fungi, isolated from soil in the central Brazil, and Beauveria bassiana ATCC 7159 were evaluated for their capability of quercetin biotransformation. Biotransformation processes were carried out for 24 up to 96 hours and monitored by mass spectrometry analyses of the culture broth. All strains were able to metabolize quercetin, forming mammalian metabolites. The results were different from those presented by other microorganisms previously utilized, attrackting attention because of the great diversity of reactions. Methylated, sulphated, monoglucuronidated, and glucuronidated conjugated metabolites were simultaneously detected. Biotransformações microbianas constituem uma alternativa importante como modelo para o estudo do metabolismo de medicamentos em mamíferos e são empregadas em processos sintéticos industriais com propósitos farmacêuticos. Diversos microrganismos com potencial para biotransformação têm sido encontrados através de screening intensivo e aplicados comercialmente. Dez cepas de fungos filamentosos do gênero Beauveria, isolados na região central do Brasil, e a cepa Beauveria bassiana ATCC 7159 foram avaliadas quanto à capacidade de biotransformação da quercetina. As reações de biotransformações foram realizadas por um período de 24 a 96 horas, e monitoradas através de espectrometria de massas do meio reacional. Todas as cepas foram capazes de metabolizar a quercetina, formando metabólitos encontrados nos mamíferos. Os resultados foram diferentes dos resultados apresentados por outros microrganismos utilizados anteriormente e chamam a atenção devido à diversidade das reações evidenciadas. Diferentes metabólitos conjugados foram detectados simultaneamente: metilados, sulfatados, monoglicuronados, e glicuronados
- Open Access
- 19 April 2007
- Published by Universidade Federal de Goias in Revista de Patologia Tropical / Journal of Tropical Pathology
- Vol. 33 (1)
CITOCROMOS P450 E BIOTRANSFORMAÇÃO MICROBIANA
Resumo O interesse científico sobre o sistema enzimático citocromo P450 tem aumentado consideravelmente. Sua participação no metabolismo oxidativo de xenobióticos propicia a conversão de compostos lipofihicos em hidrofíhicos, facilitando a excreção celular. A similaridade desse sistema em mamíferos e em diversos microrganismos permite empregar a biotransformação microbiana para obter quantidades consideráveis de metabólitos de difícil obtenção por meio de modelos animais ou por síntese química. Os metabólitos obtidos são identificados e caracterizados quanto às suas estruturas químicas, propriedades e atividades biológicas. Diversos fármacos ativos em doenças tropicais tem sido pesquisados por intermédio dessa metodologia.
- 19 April 2007
- Published by Universidade Federal de Goias in Revista de Patologia Tropical / Journal of Tropical Pathology
- Vol. 33 (1)
Open AccessCITOCROMOS P450 E BIOTRANSFORMAÇÃO MICROBIANA
Resumo O interesse científico sobre o sistema enzimático citocromo P450 tem aumentado consideravelmente. Sua participação no metabolismo oxidativo de xenobióticos propicia a conversão de compostos lipofihicos em hidrofíhicos, facilitando a excreção celular. A similaridade desse sistema em mamíferos e em diversos microrganismos permite empregar a biotransformação microbiana para obter quantidades consideráveis de metabólitos de difícil obtenção por meio de modelos animais ou por síntese química. Os metabólitos obtidos são identificados e caracterizados quanto às suas estruturas químicas, propriedades e atividades biológicas. Diversos fármacos ativos em doenças tropicais tem sido pesquisados por intermédio dessa metodologia.